Rosuvastatin is contraindicated: In patients with hypersensitivity to the active substance or to any of the excipients.
In patients with active liver disease including unexplained, persistent elevations of serum transaminases and any serum transaminase elevation exceeding 3 times the upper limit of normal (ULN).
In patients with severe renal impairment (creatinine clearance <30 ml/min).
In patients with myopathy.
In patients receiving concomitant combination of sofosbuvir/velpatasvir/voxilaprevir.
In patients receiving concomitant ciclosporin.
During pregnancy and lactation and in women of childbearing potential not using appropriate contraceptive measures. The 40 mg dose is contraindicated in patients with pre-disposing factors for myopathy/rhabdomyolysis. Such factors include: Moderate renal impairment (creatinine clearance < 60 ml/min); Hypothyroidism; Personal or family history of hereditary muscular disorders; Previous history of muscular toxicity with another HMG-CoA reductase inhibitor or fibrate; Alcohol abuse; Situations where an increase in plasma levels may occur; Asian patients; Concomitant use of fibrates.
                                
                            Other Services
                            
                            
                            Country
                            Account
                            
                         
 
            
 
         
                 
                                     
                             
                                             
                                             Sign Out
 Sign Out
                                     
                                             
                                             
                                            